Tomiyuki Sugi

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Clinical characteristics and risk factors for pomalidomide-induced skin rash: Implications for pharmacist-led monitoring in real-world multiple myeloma care.

Clinical characteristics and risk factors for pomalidomide-induced skin rash: Implications for pharmacist-led monitoring in real-world multiple myeloma care.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: June 17, 2026

Effects of a pharmacist-led GAIN approach on long-acting injectables in schizophrenia.

Effects of a pharmacist-led GAIN approach on long-acting injectables in schizophrenia.

Journal: Journal of the American Pharmacists Association : JAPhA

Published: March 23, 2026

Increased trough concentration of venetoclax when combined with itraconazole for acute myeloid leukemia.

Increased trough concentration of venetoclax when combined with itraconazole for acute myeloid leukemia.

Journal: Annals of hematology

Published: December 22, 2023

Prevention of pneumocystis pneumonia in patients with hematological diseases: Efficacy of low-dose atovaquone.

Prevention of pneumocystis pneumonia in patients with hematological diseases: Efficacy of low-dose atovaquone.

Journal: International journal of clinical pharmacology and therapeutics

Published: August 25, 2023

Analysis of anti-SARS-CoV-2 IgG antibody titers after mRNA booster vaccination in patients with nonmalignant hematological disorders

Analysis of anti-SARS-CoV-2 IgG antibody titers after mRNA booster vaccination in patients with nonmalignant hematological disorders

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: March 29, 2023

Successful Elimination of SARS-CoV-2 Following Vaccination with BNT162b2 after Prolonged Viral Infection in an Immunocompromised Lymphoma Patient.

Successful Elimination of SARS-CoV-2 Following Vaccination with BNT162b2 after Prolonged Viral Infection in an Immunocompromised Lymphoma Patient.

Journal: Internal medicine (Tokyo, Japan)

Published: July 19, 2022

SARS-CoV2 anti-spike IgG response following COVID-19 mRNA vaccination (BNT162b2) in patients with hematological disorders

SARS-CoV2 anti-spike IgG response following COVID-19 mRNA vaccination (BNT162b2) in patients with hematological disorders

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: May 01, 2022

Preceding bortezomib administration for a certain period reduces the risk of lenalidomide-induced skin rash.

Preceding bortezomib administration for a certain period reduces the risk of lenalidomide-induced skin rash.

Journal: Journal of clinical pharmacy and therapeutics

Published: May 17, 2021

Analysis of risk factors for lenalidomide-associated skin rash in patients with multiple myeloma.

Analysis of risk factors for lenalidomide-associated skin rash in patients with multiple myeloma.

Journal: Leukemia & lymphoma

Published: January 29, 2021

Simple desensitization protocol for multiple myeloma patients with lenalidomide-induced skin rash: Case series.

Simple desensitization protocol for multiple myeloma patients with lenalidomide-induced skin rash: Case series.

Journal: Journal of clinical pharmacy and therapeutics

Published: January 28, 2021

Determination of the concentration of gilteritinib in human plasma using HPLC.

Determination of the concentration of gilteritinib in human plasma using HPLC.

Journal: Biomedical chromatography : BMC

Published: September 11, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026